1. Autophagy NF-κB Metabolic Enzyme/Protease Immunology/Inflammation Anti-infection Apoptosis
  2. Autophagy Reactive Oxygen Species (ROS) Bacterial Apoptosis
  3. Rhein

Rhein  (Synonyms: Rheic Acid; Rhubarb yellow; Monorhein)

Cat. No.: HY-N0105 Purity: 99.56%
Handling Instructions Technical Support

Rhein is an anthraquinone compound with anti-inflammatory, antioxidant, and anti-cancer effects[1].

For research use only. We do not sell to patients.

CAS No. : 478-43-3

Size Price Stock Quantity
100 mg In-stock
500 mg In-stock
1 g In-stock
5 g In-stock
10 g In-stock
50 g In-stock
100 g In-stock
> 100 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 17 publication(s) in Google Scholar

Other Forms of Rhein:

Top Publications Citing Use of Products

    Rhein purchased from MedChemExpress. Usage Cited in: J Inflamm Res. 2025 Jan 30:18:1395-1412.  [Abstract]

    Toxicity of different doses of Rhein (5, 10, 20, 40, 60, 80, 100 μM) on R-PMVEC was detected by CCK8.

    Rhein purchased from MedChemExpress. Usage Cited in: J Inflamm Res. 2025 Jan 30:18:1395-1412.  [Abstract]

    MARK4 mRNA relative expression in R-PMVEC treated with different doses of Rhein (5, 20, 40 μM) was performed by Real-Time quantitative PCR.

    Rhein purchased from MedChemExpress. Usage Cited in: J Inflamm Res. 2025 Jan 30:18:1395-1412.  [Abstract]

    Protein expression levels of MARK4 and p-MAP4 (S1073) in R-PMVEC treated with different doses of Rhein (5, 20, 40 μM) were performed by Western blot.

    Rhein purchased from MedChemExpress. Usage Cited in: J Inflamm Res. 2025 Jan 30:18:1395-1412.  [Abstract]

    Rhein (200, 250 mg/kg, i.g.) induced kidney histopathology sections showed edema, necrosis, and immune cell infiltration.

    Rhein purchased from MedChemExpress. Usage Cited in: J Inflamm Res. 2025 Jan 30:18:1395-1412.  [Abstract]

    Immunofluorescence staining showed that apparent MT damage happened in the lungs of SAP group rats. After administration of the MARK4 inhibitor or Rhein (150 mg/kg, i.g.), the MT damage was significantly alleviated.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Rhein is an anthraquinone compound with anti-inflammatory, antioxidant, and anti-cancer effects[1].

    Cellular Effect
    Cell Line Type Value Description References
    A549 IC50
    0.08 mM
    Compound: Rhein
    Antiproliferative activity against human A549 cells
    Antiproliferative activity against human A549 cells
    10.1039/C6MD00252H
    A549 IC50
    120.4 μM
    Compound: Rhein
    Antiproliferative activity in human A549 cells after 72 hrs by MTT assay
    Antiproliferative activity in human A549 cells after 72 hrs by MTT assay
    10.1039/C6MD00252H
    A549 IC50
    138 μM
    Compound: Rhein
    Antiproliferative activity against human A549 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
    [PMID: 32739648]
    A549 IC50
    265.59 μM
    Compound: Rhein
    Anticancer activity against human A549 cells incubated for 48 hrs by MTT assay
    Anticancer activity against human A549 cells incubated for 48 hrs by MTT assay
    [PMID: 38516604]
    A549 IC50
    77.11 μg/mL
    Compound: A
    Antiproliferative activity against human A549 cells measured after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells measured after 48 hrs by MTT assay
    [PMID: 35963130]
    A549 IC50
    95.8 μM
    Compound: Rhein
    Antitumor activity against human A549 cells after 3 days by SRB assay
    Antitumor activity against human A549 cells after 3 days by SRB assay
    [PMID: 25050882]
    Bel-7402 IC50
    0.11 mM
    Compound: Rhein
    Antiproliferative activity against human Bel7402 cells after 24 to 72 hrs by MTT assay
    Antiproliferative activity against human Bel7402 cells after 24 to 72 hrs by MTT assay
    10.1039/C6MD00252H
    Bel-7402 IC50
    120.27 μM
    Compound: Rhein
    Antiproliferative activity in human Bel7402 cells after 72 hrs by MTT assay
    Antiproliferative activity in human Bel7402 cells after 72 hrs by MTT assay
    10.1039/C6MD00252H
    Bel-7402 IC50
    136.19 μM
    Compound: Rhein
    Antiproliferative activity in 5-FU resistant human Bel7402 cells after 72 hrs by MTT assay
    Antiproliferative activity in 5-FU resistant human Bel7402 cells after 72 hrs by MTT assay
    10.1039/C6MD00252H
    CNE IC50
    81.7 μM
    Compound: Rhein
    Antiproliferative activity against human CNE cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
    Antiproliferative activity against human CNE cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
    [PMID: 32739648]
    CNE IC50
    > 100 μM
    Compound: Rhein
    Cytotoxicity against human CNE cells after 48 hrs by MTT assay
    Cytotoxicity against human CNE cells after 48 hrs by MTT assay
    [PMID: 24378217]
    COLO 320DM IC50
    62.5 μM
    Compound: Rhein
    Cytotoxicity against human COLO320DM cells
    Cytotoxicity against human COLO320DM cells
    [PMID: 24378217]
    HCT-116 IC50
    115.7 μM
    Compound: Rhein
    Antiproliferative activity in human HCT116 cells after 72 hrs by MTT assay
    Antiproliferative activity in human HCT116 cells after 72 hrs by MTT assay
    10.1039/C6MD00252H
    HCT-116 IC50
    13 μM
    Compound: 5
    Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay
    Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay
    [PMID: 17949858]
    HCT-116 IC50
    135 μM
    Compound: Rhein
    Cytotoxicity against human HCT116 cells
    Cytotoxicity against human HCT116 cells
    [PMID: 24378217]
    HCT-116 IC50
    > 100 μM
    Compound: Rhein
    Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
    Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
    [PMID: 24378217]
    HL-60 IC50
    0.1 mM
    Compound: Rhein
    Antiproliferative activity against human HL60 cells
    Antiproliferative activity against human HL60 cells
    10.1039/C6MD00252H
    HUVEC IC50
    89.74 μM
    Compound: Rhein
    Cytotoxicity against human HUVEC after 48 hrs by MTT assay
    Cytotoxicity against human HUVEC after 48 hrs by MTT assay
    [PMID: 24378217]
    HeLa IC50
    92.2 μM
    Compound: Rhein
    Antitumor activity against human HeLa cells after 3 days by SRB assay
    Antitumor activity against human HeLa cells after 3 days by SRB assay
    [PMID: 25050882]
    HeLa IC50
    > 100 μM
    Compound: Rhein
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
    [PMID: 24378217]
    HepG2 IC50
    0.71 mM
    Compound: Rhein
    Antiproliferative activity against human HepG2 cells
    Antiproliferative activity against human HepG2 cells
    10.1039/C6MD00252H
    HepG2 IC50
    100.8 μM
    Compound: Rhein
    Antiproliferative activity in human HepG2 cells after 72 hrs by MTT assay
    Antiproliferative activity in human HepG2 cells after 72 hrs by MTT assay
    10.1039/C6MD00252H
    HepG2 IC50
    12.3 μM
    Compound: 5
    Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay
    Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay
    [PMID: 17949858]
    HepG2 IC50
    74.6 μM
    Compound: Rhein
    Antiproliferative activity against human HepG2 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
    [PMID: 32739648]
    HepG2 IC50
    > 100 μM
    Compound: Rhein
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
    [PMID: 24378217]
    MCF7 IC50
    0.13 mM
    Compound: Rhein
    Antiproliferative activity against human MCF7 cells
    Antiproliferative activity against human MCF7 cells
    10.1039/C6MD00252H
    MCF7 IC50
    105.7 μM
    Compound: Rhein
    Antiproliferative activity in human MCF7 cells after 72 hrs by MTT assay
    Antiproliferative activity in human MCF7 cells after 72 hrs by MTT assay
    10.1039/C6MD00252H
    MDA-MB-231 IC50
    41.8 μM
    Compound: Rhein
    Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
    [PMID: 32739648]
    SCC-4 IC50
    0.058 mM
    Compound: Rhein
    Antiproliferative activity against human SCC4 cells
    Antiproliferative activity against human SCC4 cells
    10.1039/C6MD00252H
    SGC-7901 IC50
    0.15 mM
    Compound: Rhein
    Antiproliferative activity against human SGC7901 cells after 24 to 72 hrs by MTT assay
    Antiproliferative activity against human SGC7901 cells after 24 to 72 hrs by MTT assay
    10.1039/C6MD00252H
    SK-OV-3 IC50
    71.5 μM
    Compound: Rhein
    Antiproliferative activity against human SK-OV-3 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
    Antiproliferative activity against human SK-OV-3 cells assessed as cell growth inhibition incubated for 48 hrs by MTT assay
    [PMID: 32739648]
    WI-38 IC50
    324.9 μM
    Compound: Rhein
    Cytotoxicity against human WI-38 cells incubated for 48 hrs by MTT assay
    Cytotoxicity against human WI-38 cells incubated for 48 hrs by MTT assay
    [PMID: 38516604]
    WI-38 IC50
    92.34 μg/mL
    Compound: A
    Antiproliferative activity against human WI-38 cells measured after 48 hrs by MTT assay
    Antiproliferative activity against human WI-38 cells measured after 48 hrs by MTT assay
    [PMID: 35963130]
    In Vitro

    Rhein (0-80 μM, 72 h) inhibits the viability of NB4 cells in a dose-dependent manner[2].
    Rhein (5 μM, 72 h) increases semi-adherent, macrophage-like cells, and expression of CD11b, CD14, CCR-1 and CCR-2, and increases ROS production and phagocytosis in ATRA-activated NB4 cells[2].
    Rhein (5 μM, 72 h) induces NB4 cell death by activating apoptosis and inhibiting the mTOR pathway [2].
    Rhein (50-200 μM, 48 h) inhibits angiogenesis in MCF-7 and MDA-MB-435 cells[4].
    Rhein (0-50 μM, 24 h) inhibits HUVEC roliferation, migration, invasion, and tube formation (inhibits VEGF165, EGF in supernatant and HIF-1α in nuclear extract)[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    RT-PCR[2]

    Cell Line: acute promyelocytic leukemia (APL) cell (NB4 cells)
    Concentration: 5 μM
    Incubation Time: 72 h
    Result: Increaseed mRNA expression of PU.1, C/EBPA, and C/EBPE.
    Increaseed ATRA activated mRNA expression of CCR1 and CCR2.

    Western Blot Analysis[2]

    Cell Line: NB4 cells
    Concentration: 0-40 μM
    Incubation Time: 48 and 72 h
    Result: Increased the expression of cleaved caspase-3, Bax.
    Decreased the expression of Bcl-xl, procaspase-3.
    In Vivo

    Rhein (10-40 mg/kg, i.g.) protects against Acetaminophen (HY-66005)-induced hepatic and renal toxicity in rats[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: 2.5 g/kg APAP (i.g.) induced rats[3]
    Dosage: 10, 20 and 40 mg/kg
    Administration: i.g.
    Result: Ameliorated histopathological damage of liver and kidney.
    Reduced GPT, GOT, UREA and CREA levels and ROS production.
    Restored NO, MDA, GSH contents.
    Molecular Weight

    284.22

    Formula

    C15H8O6

    CAS No.
    Appearance

    Solid

    Color

    Light yellow to yellow

    SMILES

    O=C(C(C=C1C2=O)=CC(O)=C1C(C3=C2C=CC=C3O)=O)O

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 2 years
    -20°C 1 year
    Solvent & Solubility
    In Vitro: 

    DMSO : 7.14 mg/mL (25.12 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.5184 mL 17.5920 mL 35.1840 mL
    5 mM 0.7037 mL 3.5184 mL 7.0368 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: 1.67 mg/mL (5.88 mM); Suspended solution; Need ultrasonic

      This protocol yields a suspended solution of 1.67 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (16.7 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  0.5% CMC-Na/saline water

      Solubility: 10 mg/mL (35.18 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.56%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 3.5184 mL 17.5920 mL 35.1840 mL 87.9600 mL
    5 mM 0.7037 mL 3.5184 mL 7.0368 mL 17.5920 mL
    10 mM 0.3518 mL 1.7592 mL 3.5184 mL 8.7960 mL
    15 mM 0.2346 mL 1.1728 mL 2.3456 mL 5.8640 mL
    20 mM 0.1759 mL 0.8796 mL 1.7592 mL 4.3980 mL
    25 mM 0.1407 mL 0.7037 mL 1.4074 mL 3.5184 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Rhein
    Cat. No.:
    HY-N0105
    Quantity:
    MCE Japan Authorized Agent: